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Abstract
Background: The production of high yields of recombinant proteins is an enduring bottleneck in
the post-genomic sciences that has yet to be addressed in a truly rational manner. Typically
eukaryotic protein production experiments have relied on varying expression construct cassettes
such as promoters and tags, or culture process parameters such as pH, temperature and aeration
to enhance yields. These approaches require repeated rounds of trial-and-error optimization and
cannot provide a mechanistic insight into the biology of recombinant protein production. We
published an early transcriptome analysis that identified genes implicated in successful membrane
protein production experiments in yeast. While there has been a subsequent explosion in such
analyses in a range of production organisms, no one has yet exploited the genes identified. The aim
of this study was to use the results of our previous comparative transcriptome analysis to engineer
improved yeast strains and thereby gain an understanding of the mechanisms involved in high-
yielding protein production hosts.
Results: We show that tuning BMS1 transcript levels in a doxycycline-dependent manner resulted
in optimized yields of functional membrane and soluble protein targets. Online flow
microcalorimetry demonstrated that there had been a substantial metabolic change to cells
cultured under high-yielding conditions, and in particular that high yielding cells were more
metabolically efficient. Polysome profiling showed that the key molecular event contributing to this
metabolically efficient, high-yielding phenotype is a perturbation of the ratio of 60S to 40S
ribosomal subunits from approximately 1:1 to 2:1, and correspondingly of 25S:18S ratios from 2:1
to 3:1. This result is consistent with the role of the gene product of BMS1 in ribosome biogenesis.
Conclusion: This work demonstrates the power of a rational approach to recombinant protein
production by using the results of transcriptome analysis to engineer improved strains, thereby
revealing the underlying biological events involved.
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Advances in understanding cellular function rely on
improving our knowledge of protein behaviour, protein-
protein interactions, and the complex interplay of pro-
teins with other biomolecules. Whilst structures have
been solved for many individual proteins, the challenge
now is to expand this specific knowledge more generically
to physiologically-important, difficult-to-study eukaryotic
proteins and to understand the interplay between them in
complex systems. Understanding the structure and func-
tion of human proteins, and particularly membrane pro-
teins, will not only disclose the underlying structural basis
of human function but is vital in the development of new
drugs in the fight against human disease [1].
As they are not naturally highly abundant, membrane
proteins and many soluble eukaryotic proteins must be
over-produced for the detailed studies that will reveal
their biochemical, functional and structural characteris-
tics. Therefore obtaining high yields of functional, recom-
binant protein remains a major bottleneck in
contemporary bioscience [2]. We have shown that the
root of the problem is the host organism [3], and the lack
of knowledge about the intricate cellular biology within.
Typically eukaryotic protein production experiments have
relied on varying either promoter and fusion tag combina-
tions in expression constructs [4] or culture process
parameters such as pH, temperature and aeration [5] to
enhance yields. These approaches require repeated rounds
of trial-and-error optimization and cannot provide a
mechanistic insight into the biology of recombinant pro-
tein production as only external parameters are varied.
This is also true of approaches which rely on the mutation
of the protein target to improve its production yields [6].
The genomics revolution, however, has allowed us to take
a broader but still rational approach to such optimization,
which we previously adopted for recombinant membrane
protein production [3] where we reported 39 host cell (S.
cerevisiae) genes whose expression was significantly
altered when the glycerol facilitator, Fps1, was produced
under high-yielding conditions (20°C, pH5) compared to
low-yielding standard growth conditions (30°C, pH5).
Although similar studies were also subsequently per-
formed in other hosts [7,8], mechanistic insight into suc-
cessful recombinant protein production has remained
elusive.
Building on our previous transcriptome analysis [3], we
show here how we identified high-yielding strains for the
well-characterized [9-11] eukaryotic glycerol facilitator,
Fps1, which is a non-trivial production target for further
structural study. Specifically, we characterized spt3Δ, srb5Δ
and gcn5Δ as effective production hosts for Fps1, where
the yield improvement was up to a factor of 9 over the cor-
responding wild-type control. Improved yields of Fps1
were not explained by changes in promoter activity or
FPS1 transcript number, but a post-transcriptional mech-
anism was suggested by the observation that each strain
had elevated levels of BMS1 transcript compared to wild-
type, as Bms1, the gene product of BMS1, is involved in
ribosome biogenesis [12]. Subsequent overexpression of
BMS1 in a doxycycline-dependent manner revealed that
maximal membrane protein yield is correlated with an
optimum level of BMS1 transcript for Fps1 and can be
specifically tuned to maximize yields of other functional
membrane (human adenosine 2A receptor) as well as sol-
uble (green fluorescent protein) protein targets. By alter-
ing the amount of BMS1 transcript, the metabolism of
high-yielding cultures changed substantially as deter-
mined by on-line flow microcalorimetry. This coincided
with the ratio of 60S and 40S ribosomal subunits being
perturbed, which we propose is the key to maximizing
recombinant protein yields. This work demonstrates the
power of a rational approach to recombinant protein pro-
duction by finally offering an insight into the actual mech-
anisms involved.
Results
Three host strains deleted for genes involved in 
transcriptional regulation give substantially higher Fps1 
yields than the wild-type parent strain
43 deletion strains were screened in shake-flasks to test
the effect of genes that we had previously shown to be
down-regulated under high-yielding production condi-
tions of our target protein, Fps1 [3], or that were known
to be from related pathways, especially in cases where a
deletion strain was non-viable. The amount of mem-
brane-bound Fps1 from late-log phase shake-flask cul-
tures was quantified from immunoblots relative to the
wild-type yield, with all immunoblot signals being below
saturation. A cut-off point twice that of the wild-type was
set for selecting strains for further study resulting in three
strains being analyzed in bioreactors. The three deleted
genes are known to be components of the transcriptional
SAGA (GCN5, SPT3) and mediator (SRB5) complexes
[13]. It has been hypothesized that SAGA may have a role
in the transcription of 10% of genes, most of which seem
to be stress-induced and that this might reflect the need to
balance inducible stress responses with the steady output
of housekeeping genes [14]. In contrast, the mediator
complex appears to be required for all transcriptional
events and transmits regulatory signals from transcription
factors to RNA polymerase II, interacting directly with the
unphosphorylated carboxy-terminal domain of RNA
polymerase II, forming part of the pre-initiation complex,
thus stimulating transcription [15].
Figure 1 summarizes the Fps1 overproduction data from
bioreactors in three S. cerevisiae strains and demonstrates
that the spt3Δ strain offers a factor of 9–69 medium-Page 2 of 14
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type, the srb5Δ strain a factor of 1–18 increase and the
gcn5Δ strain a factor of 4–46 increase. The spt3Δ strain
gave the highest final yield of a factor of 54 over our inter-
nal control. We also noted that the move from shake flask,
where these strains were initially screened, to bioreactor
had resulted in significant yield improvements for each
strain relative to the wild-type: the greatest increase in
yield compared to the wild-type strain in shake-flasks was
only a factor of 5 for the spt3Δ and srb5Δ strains (data not
shown). The choice of medium also had a role to play
with the relationship between increased yield and
medium composition being strain independent: 2 × CBS
was optimal in all cases (Figure 1), although CSM revealed
greater improvements in the deletion strains compared to
wild-type. There was no correlation between increased
biomass and Fps1 yield since the highest yield of Fps1 was
observed in early-to-mid glucose phase samples, whereas
the highest biomass was always achieved in the ethanol
phase. All mutant strains grew to lower cell densities than
the wild type and exhibited slow-growth phenotypes. The
reported auxotrophy of srb5Δ for myo-inositol [16], was
not a significant contributor to its phenotype under our
experimental conditions with it consistently out-perform-
ing the wild type in Fps1 overproduction (Figure 1).
As the host strains were all deleted for genes involved in
transcription, real time quantitative PCR (Q-PCR) was
used to measure the levels of plasmid-borne FPS1 (Table
1) to determine whether this was correlated with the pro-
tein yields observed in Figure 1. Endogenous TPI1 levels
were used as an indicator of TPI1 promoter activity, as
plasmid-borne FPS1 was cloned under the control of the
TPI1 promoter and it was assumed that the activities of
this promoter in both contexts would be similar. Within
Analysis of yields of Fps1 from three deletion strains cultured in 2 L bioreactorsFigure 1
Analysis of yields of Fps1 from three deletion strains cultured in 2 L bioreactors. Fps1 yields are reported relative 
to a control sample, which previously represented our highest Fps1 yield obtained [3], as described in the Methods section. 
The y-axis shows the factor improvement over the control. Maximum yields are indicated from four immunoblots from dupli-
cate bioreactor cultures. Error bars represent the standard deviation (n = 4). White bars are the values for cells grown in CSM 
medium, pale grey for CSM medium supplemented with 10 μg/mL myo-inositol and dark grey bars for 2 × CBS medium.
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Table 1: Fps1 yield correlates with BMS1 transcript number in 
the host cell
Copies mRNA/cell
Strain TPI1 FPS1 BMS1
wild-type 53.6 (5.0) 60.1 (18.2) 0.1 (0.0)
gcn5Δ 15.4 (3.4)** 61.5 (3.0) 0.7 (0.2)**
spt3Δ 12.5 (1.8)** 64.9 (26.0) 0.6 (0.1)**
srb5Δ 38.2 (12.5)* 87.4 (1.5) 0.7 (0.2)**
Analysis of mRNA from shake-flask cultures was performed using real 
time quantitative PCR. The data were normalized using the reference 
genes ACT1 and PDA1 and the signal was scaled to mRNA copies/cell 
according to a SAGE study [32], in which copies of mRNA/cell of the 
reference genes had previously been determined. Standard deviation 
in parentheses was calculated for the samples (n = 4). A single asterisk 
denotes significance at the P < 0.05 level (paired 2-tailed T-test), and a 
double asterisk at P < 0.01 level.Page 3 of 14
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even though the deletion strains apparently had lower
promoter activity (Table 1). We thus concluded that
changes in the yield of Fps1 were likely to be explained by
post-transcriptional events, in line with our earlier obser-
vations [3].
Up-regulation of BMS1 is a marker of high-yielding 
conditions
Using Q-PCR, we examined changes in genes that we had
previously shown to be up- or down-regulated under
high-yielding production conditions [3] or that were
known to be from related pathways. From this, we noted
a clear relationship between Fps1 yield and a factor of 6–
7 increase in BMS1 transcript number over wild-type in all
three host strains (Table 1). In order to assess whether up-
regulation of BMS1 over wild-type levels is a marker of
high-yielding strains, we screened three further strains,
two giving wild-type- (spt8Δ, med6Δ) and one giving
improved (yTHCSRB6, where SRB6 is over-expressed in a
doxycycline-repressible manner) Fps1 production yields.
Table 2 shows that only yTHCSRB6 had an increase in
BMS1 transcript number over wild-type, confirming that
BMS1 up-regulation over wild-type levels is a marker of
improved yields.
We next used a doxycycline-repressible BMS1 overexpres-
sion strain from the Open Biosystems yTHC collection
(Thermo Fisher Scientific, UK) that allows gene expres-
sion to be tuned by the addition of doxycycline to the
growth medium. This permitted further examination of
the correlation between up-regulation of BMS1 and
recombinant Fps1 yield. We found that in shake flask cul-
tures, yield varied as doxycycline concentration (and
hence BMS1 transcript number) was varied, as shown in
Figure 2. Maximal Fps1 yields of a factor of 78 over wild-
type were obtained at 0.5 μg/mL doxycycline. On cultur-
ing this strain in a bioreactor in the presence of 0.5 μg/mL
doxycycline, the yield improvement over wild-type rose
by up to a factor of 137 (data not shown). At 0.5 μg/mL
doxycycline, the BMS1 level was 0.5 copies/cell (standard
deviation = 0.1; n = 2) compared with that of 0.1 copies/
cell in the wild type strain, then decreased with increasing
doxycycline concentration (Figure 2).
The BMS1 overexpression strain, yTHCBMS1, can be 
further tuned to improve the functional yield of the G-
protein coupled receptor, hA2aR, and soluble green 
fluorescent protein
In order to examine whether our screening strategy using
Fps1 as a target, had resulted in an Fps1-specific result, we
tested the human G-protein coupled receptor, A2aR in our
best-performing strain. Figure 3A shows that the improve-
ment in active hA2aR as assessed by radioligand binding
was small for cells cultured under conditions optimized
for Fps1 production (0.5 μg/mL doxycycline). On examin-
ing whether hA2aR production could be tuned further, we
confirmed that maximal binding activity was obtained at
a doxycycline concentration of 10 μg/mL (where BMS1
levels were approximately three times those in wild-type
cells). Analysis of the binding curves confirmed that this
was due to an increase in receptor expression (i.e. the
maximum amount of ZM241385 bound) and not
because of any change in the affinity of the receptor for the
radioligand. Furthermore, the strain could be tuned to
maximize yields of functional green fluorescent protein,
doubling wild-type yields at 10 μg/mL doxycycline when
grown in 50 mL shake-flask cultures (Figure 3B). These
results suggested that the up-regulation of BMS1 in a tar-
get-protein-specific manner might be the key to maximiz-
ing yields for a range of proteins.
On-line flow microcalorimetry data indicate different 
metabolic activity in high-yielding versus low-yielding 
strains
We noted that high-yielding strains had lower growth
rates than low yielding strains as previously observed in a
wide range of cell-types, including engineered mamma-
lian cells [17]. In order to assess whether this was accom-
panied by changes in metabolic activity, we used on-line
flow microcalorimetry to measure the heat output of the
recombinant protein-producing strains (Figure 4). The
calorimetry traces in the glucose phase, where protein pro-
duction peaks [3], were similar under all conditions
except the maximal Fps1-yielding one (Figure 4). In the
latter case, the trace mirrored the OD600-derived growth
curve of yTHCBMS1 in the presence of 0.5 μg/mL doxycy-
cline (Figure 4), consistent with the metabolic burden of
increased recombinant protein production.
Table 2: BMS1 up-regulation can be used as a marker for selecting high-yielding strains
Strain Copies BMS1 mRNA/cell Fps1 yield relative to wild-type
wild-type 0.1 (0.1) 100 (27.0)
spt8Δ 0.2 (0.0) 104 (28.0)
med6Δ 0.2 (0.1) 55.6 (15.0)
yTHCSRB6 0.8 (0.3)** 310 (12.0)**
Analysis of mRNA was performed as described in the legend to Table 1, and of Fps1 yield as described in the Methods section. Standard deviation 
in parentheses was calculated for the samples (n = 4). A double asterisk denotes significance at the P < 0.01 level (paired 2-tailed T-test).SPT8 
encodes a subunit of the SAGA complex, required for inhibition at some promoters. MED6 and SRB6 encode subunits of the mediator complex.Page 4 of 14
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Maximum yields of Fps1 are achieved by tuning BMS1 transcript number in a doxycycline-repressible system (yTHC)Figure 2
Maximum yields of Fps1 are achieved by tuning BMS1 transcript number in a doxycycline-repressible system 
(yTHC). Fps1 yield in shake flasks is presented for the yTHCBMS1 overexpression strain cultured in 2 × CBS medium with 
varying amounts of doxycycline (the concentration in μg/mL is shown in parentheses next to each point), thereby varying the 
copies of BMS1 RNA/cell. The y-axis shows the factor improvement over the control, as for Figure 1. For comparison, data for 
the wild-type and the three deletion strains presented in Figure 1 (srb5Δ, spt3Δ and gcn5Δ) are also shown. Inset is a typical 
anti-HA-tag immunoblot showing Fps1 yields for 75 μg total wild-type membrane (lane 1), and 15 μg total yTHCBMS1 mem-
branes extracted from shake-flask cultures grown in the presence of 0 (lane 2), 0.25 (lane 3), 0.5 (lane 4) and 10 μg/mL (lane 5) 
doxycycline. The markers (M) are 62, 98, 188 kDa ascending from the bottom of the gel upwards.
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The yTHCBMS1 strain, which produces the highest yields of Fps1, can also be used to improve the functional yield of other proteinsFigure 3
The yTHCBMS1 strain, which produces the highest yields of Fps1, can also be used to improve the functional 
yield of other proteins. (A) Binding of ZM241385 on yeast membranes producing the G-protein coupled receptor, hA2aR is 
shown for duplicate determinations. Error bars represent the standard deviation (n = 2). Also shown are the Kd (nM) and Bmax 
(pmol receptor/mg protein) values with standard deviation given in parentheses (n = 2). (B) The yTHCBMS1 strain (grey bars) 
improves the functional yield of green fluorescent protein by a factor of 2 over wild-type (white bars). Error bars represent the 
standard deviation (n = 3). Shown is the total GFP yield from a 50 mL culture of OD600 1.0.
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Microbial Cell Factories 2009, 8:10 http://www.microbialcellfactories.com/content/8/1/10As expected, the heat outputs in all but the maximal Fps1-
yielding conditions were indistinguishable. A natural log
plot of the glucose growth phases for the low-yielding
strains had highly similar pseudo-first order rate constants
of 0.39 h-1, 0.37 h-1and 0.32 h-1, for the wild-type in the
absence or presence of doxycycline, and yTHCBMS1 in its
absence, respectively, yielding a mean growth rate of 0.36
h-1 (where the standard deviation is 0.04). This is in excel-
lent agreement with the mean growth rate of 0.34 h-1 cal-
culated from OD600 values and dry weights (Figure 4,
lower insert) and is in line with typical growth rates for
glucose-grown S. cerevisiae in bioreactors [18]. In contrast
the mean growth rate for the maximal Fps1-yielding con-
ditions (yTHCBMS1 in the presence of 0.5 μg/mL doxycy-
cline) was calculated to be 0.21 h-1 from triplicate
determinations (standard deviation is 0.02), indistin-
guishable from 0.19 h-1 calculated from OD600 values and
dry weights (Figure 4). This is 58% of the mean growth
rate for the low-yielding strains and is clearly reflected in
the differing peak areas of the glucose growth phases (Fig-
ure 4): the corresponding heat yields for yTHCBMS1 in
the presence and absence of 0.5 μg/mL were 5.4 kJ/g and
6.5 kJ/g, respectively. This suggested a substantially differ-
ent metabolism in high-yielding compared to low-yield-
ing cultures, consistent with the different ethanol profiles
(Figure 4, upper insert).
Calorimetric profiles for the yTHCBMS1 and wild-type strainsFigu e 4
Calorimetric profiles for the yTHCBMS1 and wild-type strains. Profiles are shown for yTHCBMS1 producing Fps1 in 
the absence (white circles) or presence (black circles) of 0.5 μg/mL doxycycline. Those for the wild-type in the absence (white 
squares) or presence (black squares) of 0.5 μg/mL doxycycline overlay the former trace. The top inset panel shows the glucose 
(squares) and ethanol (circles) data for the yTHCBMS1 strain producing Fps1 in the absence (white symbols) or presence 
(black symbols) of 0.5 μg/mL doxycycline. The lower inset shows the natural log plot of the glucose phase data for the 
yTHCBMS1 strain, showing the linear fit used to calculate rate constants of 0.32 h-1 and 0.21 h-1 in the absence (white circles) 
or presence (black circles) of 0.5 μg/mL doxycycline, respectively.
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60S:40S subunit ratio in the host cell
We wished to identify a molecular event that might
explain the apparently changed metabolism of high-yield-
ing cells. As Bms1 has previously been reported to have a
role in ribosome biogenesis [12], we therefore examined
the polysome profile for yTHCBMS1 producing recom-
binant Fps1 in the presence and absence of 0.5 μg/mL
doxycycline, the former condition giving maximal Fps1
yield compared to wild-type under the same conditions.
As we had seen with the microcalorimetry traces, Figure
5A shows that the polysome profiles were similar under
all conditions except the maximal Fps1-yielding one
(lower right-hand panel) where elevated levels of free 60S
subunits were clearly apparent. There was also an
increased proportion of free 60S subunit for yTHCBMS1
in the absence of doxycycline (upper right-hand panel).
These observations were supported when the ribosomes
were disassociated with EDTA (Figure 5B): in the BMS1
overexpression strain, the relative proportion of 60S sub-
unit was shown to be increased compared to wild-type in
both the absence and presence of doxycycline. In relation
to this, in the absence of doxycycline the Fps1 yield is
increased by a factor of 10 over wild-type, while at 0.5 μg/
mL it is increased by a factor of 78, suggesting that a
change in the proportions of 60S and 40S subunits may
result in an increased protein yield. Despite differences in
the absolute peak heights, the ratio of 60S to 40S was sim-
ilar in all traces in Figure 5B except the maximal Fps1-
yielding one (lower right-hand panel). In this latter con-
dition, the relative amount of 40S was lower than in all
other conditions leading to a 2:1 ratio of 60S to 40S in
comparison with a ratio of approximately 1:1 for all other
conditions tested. Profiles for yTHCBMS1 cultured in 0,
0.25, 0.5, 1.0, 4.0 and 10.0 μg/mL doxycycline, showed
that the relative proportion of 40S subunit decreased as
expected [12] to below our detection limit with increasing
doxycycline concentration, whilst the elevated level of 60S
compared to wild-type remained essentially constant
(data not shown). In agreement with this, 25S:18S ratios
were 2:1 in the absence of doxycycline, in agreement with
typical values for wild-type S. cerevisiae [19], but increased
to 3:1, 5:1 and 7:1 at 0.5. 2.0 and 5.0 μg/mL doxycycline
respectively.
Discussion
A recent analysis of membrane protein production in E.
coli [7] reported that increases in levels of chaperones and
proteases were associated with increased membrane pro-
tein production and it was speculated that low yields were
due to limited Sec translocon capacity. Our previous tran-
script analysis identified up-regulation of SEC62 in high
yielding protein production. Sec62 is an essential subunit
of the Sec63 complex (Sec63, Sec62, Sec66 and Sec72)
and with the Sec61 complex, Kar2/BiP and Lhs1 forms a
channel competent for SRP-dependent and post-transla-
tional SRP-independent protein targeting and import into
the ER [20]. We found a SEC63 over-expression strain
from the Open Biosystems yTHC S. cerevisiae collection
did not give improved recombinant protein yields. Addi-
tionally, we found that SRP102, which encodes the signal
recognition particle receptor β subunit, was down-regu-
lated in high-yielding experiments and again that a
srp102Δ strain gave only wild-type yields of Fps1. Whilst
this does not preclude the eukaryotic secretory pathway
from having a limiting effect in S. cerevisiae translational
efficiency it does highlight clear differences between
prokaryotic and eukaryotic cells.
We found instead that a common theme in our high-
yielding strains was the up-regulation of BMS1 by a factor
of 6–7 over wild-type (Table 1) suggesting the importance
of ribosome biogenesis in maximizing production yield.
Bms1 is an essential nucleolar protein that is evolutionar-
ily conserved throughout the eukaryotic kingdom and has
been suggested to have a regulatory role in the biogenesis
of the 40S subunit [12] as well as being a GTP-binding
protein [21]. Further experiments have led to the current
model of Bms1 binding to the product of a second essen-
tial gene, Rcl1, in a GTP-dependent manner and shuttling
Rcl1 to pre-ribosomes via its affinity for U3 snoRNA [22].
Our unpublished data suggest that over-expression of
RCL1 in a doxycycline-dependent manner does not lead
to improved yields, although this could be a result of
Bms1 being limiting in a Bms1/Rcl1 complex. Nonethe-
less, recombinant protein translation was clearly
enhanced by the overexpression of BMS1 alone (Figure 2).
Interestingly, it has previously been reported that mice in
which deletion of both genes for ribosomal protein S6 led
specifically to a lack of 40S synthesis, but normal 60S syn-
thesis, in the liver survived for several weeks. Their livers
could respond to fasting and re-feeding cycles, in which
the mass of the liver nearly doubles. However, whereas
partial hepatectomy in normal animals leads to rapid re-
growth and cell division, the livers of mice defective in the
production of 40S ribosomal subunits did not re-grow
and showed no signs of cell division [23]. These results
imply that a lack of 40S ribosome biogenesis can induce a
checkpoint control that prevents cell cycle progression.
This is entirely consistent with our observed slowing of
growth that accompanied high-yielding protein produc-
tion which has been widely reported by others as a feature
of successful protein production hosts [24] and measured
by on-line gas analysis [25]. Our own data support an
interpretation that the yTHCBMS1 strain at 0.5 μg/mL
doxycycline (high yielding conditions) has low fermenta-
tive activity, since it produces 16% less ethanol than the
wild-type strain under the same conditions. Dry weights
in the high yielding condition were also 6.5% lower thanPage 8 of 14
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Polysome profiles for the yTHCBMS1 and wild-type strainsFigure 5
Polysome profiles for the yTHCBMS1 and wild-type strains. (A) Polysome OD254 profiles for yeast strains producing 
Fps1 in the absence (upper panels) or presence (lower panels) of 0.5 μg/mL doxycycline. Polysome peaks containing 2, 3 and 4 
ribosomes are visible. (B) Ribosome disassociation profiles at OD254 for 50 mM EDTA-treated samples of wild-type and 
yTHCBMS1 strains producing Fps1 in the absence and presence of 0.5 μg/mL doxycycline (upper and lower panels respec-
tively). Changes in peak heights and ratios of 60S and 40S subunits for all four conditions are tabulated.
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Microbial Cell Factories 2009, 8:10 http://www.microbialcellfactories.com/content/8/1/10in poor yielding conditions over a full growth curve (122
h) in agreement with the observation that 1 g ethanol
leads to 0.25 g dry weight in a typical yeast fermentation
[26], and so 16% less ethanol should lead to 4% less dry
weight. Furthermore the yTHCBMS1 strain had a lower
average exponential phase RQ in the presence of 0.5 μg/
mL doxycycline (RQ = 3.6) than in its absence (RQ = 4.1;
in excellent agreement with literature values for wild-type
strains grown on glucose [18]).
These observations are supported by our on-line flow
microcalorimetry data. Kemp and co-workers were
amongst the first to apply this technique to recombinant
systems [17] and recently Gill and colleagues reported
'thermal profiling' as a method for on-line analysis of the
growth of E. coli cultures expressing cyclohexanone
monooxygenase under the control of an L-arabinose pro-
moter in a multi-well format [27]. In the study presented
here, we took the next step by using thermal profiles to
rationalize the underlying mechanisms at work in our
high-yielding cultures. The reduction in heat yield we
observed suggests that high-yielding cells have a more effi-
cient metabolism than low-yielding cells. As ribosome
biogenesis is a major consumer of cellular energy
resources [28] and its regulation is intimately linked to
cell size, which in turn affects cell growth [29] as well as
influencing other features such as the way that cells
respond to stress [30], we hypothesized that the mecha-
nism underlying this changed metabolism could be due
to changes in ribosomal composition. The polysome pro-
file for the high-yielding strain in which BMS1 is overex-
pressed in the presence of optimal levels of doxycycline
for maximal Fps1 yield (at 0.5 μg/mL, Figure 5A) showed
elevated levels of 60S subunits without any significant
decrease in the levels of 80S or polysome. On further
probing this by disassociating the ribosomes with EDTA,
it could be seen that the ratio of 60S to 40S had been per-
turbed from wild-type levels of close to 1:1 to 2:1. This
might suggest a previously unreported role (direct or indi-
rect) for Bms1 in 60S biogenesis and also the possibility
of an underlying mechanism in which binding and release
of the 60S ribosomal subunit might be rate-limiting. We
speculate that perturbing the ratio of the ribosomal subu-
nits is key to maximizing recombinant protein yields by
making protein production a more efficient cellular proc-
ess. This might be influenced by an altered dynamic equi-
librium between the transcript:40S complex and the 60S
subunit which is available in greater amounts in the high-
yielding strain. Of course it is also possible that some
other component is affected by the perturbed 60S:40S
ratio; both possibilities are the subject of our ongoing
investigations.
Conclusion
Our data show that recombinant protein production can
be rationalized, guided by the results of transcriptome
analysis of the host strain response. We specifically iden-
tify BMS1 as a gene whose expression can be tuned to
facilitate high yielding protein production experiments.
Under these conditions, there is a perturbation in the ratio
of ribosomal subunits and the metabolism of the host cell
is more efficient with respect to protein production.
Methods
Vectors
The FPS1 gene was tagged at its 3' end replacing the car-
boxy-terminal threonine residue with a sequence encod-
ing three HA epitopes to permit immunodetection:
SGRIFYPYDVPDYAGYPYDVPDYAGYPYDVP-
DYAAQCGR. The HA sequences are underlined. The con-
struct was expressed from the TPI promoter in the 2
μpYX212 and pYX222 vectors (Novagen; now discontin-
ued) which contain the URA3 and HIS3 selection markers
respectively. The gene was cloned into the BamH1 and
HindIII sites and the vectors transformed into S. cerevisiae
using the lithium acetate method. The GFP (GenBank
U62636) and hA2aR [31] genes were amplified by PCR
and cloned into the HindIII and XmaI sites and the HindIII
and SalI sites of pYX212 and pYX222, respectively. The
GFP gene was cloned with an α-secretion factor to facili-
tate secretion into the culture medium.
Yeast strains and culturing conditions
S. cerevisiae BY4741 is the parental strain for the deletion
mutants spt3Δ, srb5Δ and gcn5Δ from the EUROSCARF
collection http://web.uni-frankfurt.de/fb15/mikro/euro
scarf and the yTHCBMS1 strain (Open Biosystems) used
in this study, and as such provided the wild-type control.
Yeast cells were cultured in 2.5 L bioreactors containing 2
L of either CSM ± myo-inositol or 2 × CBS. CSM was com-
posed of 1.7 g/L yeast nitrogen base (YNB) without amino
acids, 5 g/L ammonium sulphate supplemented with 2%
glucose ± 10 μg/mL additional myo-inositol, 2 × DO solu-
tion minus histidine or minus uracil (Clontech Yeast Pro-
tocols Handbook Version PR13103) and 10 mM MES pH
6. 2 × CBS was composed of 10 g/L ammonium sulphate,
6 g/L potassium dihydrogen phosphate, 1 g/L magnesium
sulphate supplemented with 2% glucose, 2 mL/L each of
trace element solution and vitamin stock solution (recipes
shown below) and 2 × DO solution minus histidine or
minus uracil. The pH was adjusted to, and maintained at,
6 via the online addition of 0.5 M NaOH. The agitation,
aeration and temperature of the cultures were maintained
at 700 rpm, 1 L per min and 30°C respectively. 1L trace
element solution was composed of the following: 15 g
EDTA, 4.5 g ZnSO4·7H20, 1 g MnCl2·4H2O, 0.3 g
CoCl2·6H2O, 0.3 g CuSO4·5H2O, 0.4 g
Na2MoO4·2H2O, 4.5 g CaCl2·2H2O, 3 g FeSO4·7H2O, 1Page 10 of 14
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1 M NaOH throughout the addition and finally adjusted
to pH 4 with 1 M HCl prior to autoclave sterilisation and
storage at 4°C. 1 L vitamin solution was composed of the
following: 0.05 g D-biotin, 1 g Ca D (+) panthothenate, 1
g nicotinic acid, 25 g myo-inositol, 1 g thiamine hydro-
chloride, 1 g pyridoxol hydrochloride and 0.2 g D-amino
benzoic acid. pH maintained at 6.5 with 1 M HCl. The
vitamin solution was filter sterilized and stored as 20 mL
aliquots at 4°C. Plasmid retention was verified by the
plating of the cells onto CSM + inositol agar in the
absence of histidine or uracil and incubation at 30°C for
4 days. To initiate each experiment, 50 mL of a given
medium were inoculated with fresh yeast cells in a baffled
shake flask and cultured for up to 72 h in a shaking incu-
bator at 30°C, 220 rpm. This pre-culture was subse-
quently used to inoculate 200 mL of the same medium in
a baffled shake flask and cultured under the conditions
outlined above to an OD600 of 1. This was then used to
inoculate the bioreactors to initial OD600 = 0.05. For the
production of hA2aR, the strains BY4714 and yTHCBMS1
were transformed with hA2aR vectors and cultured in 1.75
L 2 × CBS supplemented with 10 mM theophylline and
0.5, 1.0 or 10.0 μg/mL doxycycline. The cells were har-
vested by centrifugation once the glucose concentration of
the cultures was in the range 5 – 10 mM.
Sampling, extracellular substrate determination and 
membrane preparation
Samples were withdrawn at various points in both the glu-
cose and ethanol phases. 15 – 100 mL culture were centri-
fuged at 5000 × g, 4°C for 5 min. 0.5 mL of the
supernatant was stored at -20°C for glucose and ethanol
analyses. The cell pellets were frozen in liquid nitrogen
and stored at -80°C for subsequent membrane prepara-
tion. Ethanol analysis (10176290035, R-Biopharm, Ger-
many) was performed according to the manufacturer's
instructions. Glucose concentrations were calculated with
an Accu-Chek Active glucose analyzer (Roche Diagnostics,
UK). Cell pellets were fractionated with glass beads (1:1
ratio) in 2 mL cell breaking buffer (50 mM potassium
phosphate pH 7.4, 100 mM NaCl, 0.5 mM EDTA, 5%
glycerol, 4 mM PMSF). The cells were agitated in a Fast
Prep (Thermo Fisher Scientific, UK) at speed 6.5, employ-
ing 6 × 40 s pulses with 2 min incubations on ice between
pulses. The samples were clarified at 10,000 × g, 4°C for
30 min and the total membrane pellet recovered from the
supernatant at 100,000 × g, 4°C for 60 min. Total mem-
branes were re-suspended in 50 μL of Buffer A (20 mM
Hepes pH 8, 50 mM NaCl, 10% glycerol w/v) and the
total protein concentration determined using a Bio-Rad
(Hemel Hempstead, UK) Bradford-based assay with
bovine serum albumin as standard. Dry-weight determi-
nations were performed by collecting two samples of 5 mL
by centrifugation for 5 min at 5,000 g. The cells were
washed once in 5 mL water, dried for 24 h at 110°C, and
stored in a desiccator for 24 h before being weighed. Typ-
ical dry weights were 2.1 g/L for low-yielding conditions
and 2.0 g/L for high yielding conditions after completion
of the glucose growth phase.
Immunoblotting and yield analysis
30 – 75 μg of total membranes were loaded per lane on an
8% polyacrylamide gel and separated by SDS-PAGE at
150 V for 1.25 h. Proteins were subsequently transferred
to a nitrocellulose membrane (ProTran; Geneflow, UK) at
100 V for 1 h. The membrane was blocked with phos-
phate-buffered saline (PBS) containing 5% milk over-
night at 4°C before incubating with mouse monoclonal
anti-HA (clone 12CA5; Roche Diagnostics, UK) at a
1:5,000 dilution in PBS/5% milk for 1 h at room temper-
ature with gentle agitation. The membrane was subse-
quently washed twice with PBS/0.2% Tween 20 for 5 min
before incubating with goat anti-mouse horseradish per-
oxidase-conjugated secondary monoclonal antibody
(Sigma-Aldrich, UK) at a 1:5,000 dilution in PBS/5% milk
for 1 h at room temperature with gentle agitation. The
membrane was washed as above and developed using an
enhanced chemiluminesence detection kit (Geneflow,
UK) following the manufacturer's instructions and visual-
ized with a Chemidoc (UVItech, UK). The signal from
each lane was quantified using either UVIband or the
ImageGauge programme and was expressed as the factor
improvement over our internal control (which is the pre-
viously-reported reference yield of Fps1 per μg of total
membrane [3]) and was corrected for the amount of total
membranes loaded per lane.
Radioligand binding assay
Harvested cells were re-suspended in 30 mL breaking
buffer and disrupted at 30,000 psi for 10 min using an
Avestin C3. The samples were clarified by centrifugation at
10,000 × g, 4°C for 30 min and total membranes recov-
ered from the supernatant at 100,000 × g, 4°C for 60 min.
Total membranes were re-suspended in 2.5 mL Buffer A,
the protein concentration determined using a NanoDrop
1000 (Thermo Fisher Scientific, UK) and 0.5 mL aliquots
stored at -80°C. Membrane bound hA2aR was then deter-
mined using a radioligand binding assay based on the
protocol of Fraser [31]. Membranes at 0.5 mg/ml with 0.1
U of adenosine deaminase were incubated with varying
concentrations of 3H ZM241385 for 60 min at 30°C and
non-specific binding was defined by including 1 μM
ZM241385 in the incubations. Assays were terminated by
centrifugation at 14,000 rpm in a bench-top centrifuge for
5 min. The supernatant was discarded, the pellets washed
superficially with water and solublilized with Soluene,
which was added to scintillation fluid and then counted
to determine bound radioactivity. Binding was analyzedPage 11 of 14
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capacity.
GFP fluorescence measurements
50 mL of 2 × CBS medium were inoculated with individ-
ual yeast colonies transformed with the GFP vector and
cultured for up to 48 h in the presence or absence of vari-
ous doxycycline concentrations at 220 rpm and 30°C.
These cultures were used to inoculate fresh 50 mL 2 × CBS
medium to a final OD600 of 0.1 and were cultured as
above for 16 – 20 h. 1 mL samples were withdrawn and
the cells pelletted at 5,000 × g, 4°C for 5 min and the
supernatant collected. 200 μL supernatant were loaded in
triplicate in a black Nunc MaxiSorp 96-well plate and the
fluorescence recorded on a SpectraMax Gemini XS plate
reader (Molecular Devices, Wokingham, UK) with excita-
tion and emission wavelengths of 390 nm and 510 nm
respectively, and a cut-off of 495 nm. Doxycycline fluores-
cence accounted for less than 5% of the signal up to con-
centrations of 10 μg/mL.
RNA preparation and real time quantitative PCR
Yeast cells (60 mL) from two biological replicates and two
technical replicates were harvested and frozen in liquid
nitrogen. Total RNA was then prepared using the RNeasy
kit from Qiagen with on-column DNAse treatment, fol-
lowing the manufacturer's instructions. Analysis of mRNA
was performed using real time quantitative PCR (Q-PCR).
1.1 μg RNA was used in the cDNA reaction using the
iScript cDNA Synthesis Kit (Bio-Rad, UK). Each sample
was amplified using up to 30 cycles (20 s 94°C; 20 s 60°C;
20 s 72°C) in a Bio-Rad iCycler iQ, and the data were ana-
lyzed using iCycler IQ version 3.0. The data were normal-
ized using the reference genes PDA1 and ACT1 and the
signal was scaled to mRNA copies/cell according to a
SAGE study [32] in which copies of mRNA/cell of all the
reference genes had previously been determined.
On-line flow microcalorimetry
Flow microcalorimetric data were collected for bioreactor-
grown cultures as detailed above, in the absence or pres-
ence of 0.5 μg/mL doxycycline using a Thermal Activity
Monitor 2277 (Thermometric AB, Sweden) with a flow
vessel working volume of 0.6 cm3. The system was steri-
lized by successively pumping through solutions of sterile
deionized water, 70% ethanol (v/v), sodium hydroxide
(0.5 M) and finally sterile deionized water. The thermo-
static water bath was maintained at 30°C, a sampling
interval of 600 s was chosen in the Digitam v4.1 software
and the pumping rate was set at 48 mL/h (Watson Marlow
400–403 u/VM2, 30 rpm). The calorimeter was calibrated
at the same temperature, flow rate and amplifier setting
(1000 μW) to be used during experimental data collection
in order to establish a steady baseline deflection. Electrical
calibration was done in the culture medium. Once the
baseline was established, the inlet and outlet tubes were
placed in the bioreactor in the presence of 70% ethanol
prior to inoculation in order to maintain sterility. Power-
time data were imported into Microcal Origin 7.0 where
all subsequent data analysis was performed. Pseudo 1st
order rate constants were extracted from the calorimetric
data using the equation below [33], for a flowing system
that conforms to 1st order kinetics.
where Φ is the calorimetric output (Js-1); F is the flow rate
(dm3s-1); C is the concentration of reactant (mol dm-3); H
is the enthalpy of reaction (kJ mol-1); k is the rate constant
(s-1); τ is the residence time of reacting solution (s); t is
time (s). By plotting the natural logarithm of power
against time, a pseudo 1st order rate constant for exponen-
tial growth under the conditions employed was obtained.
This was validated against the value calculated from
OD600 and dry weight measurements. Peak areas were cal-
culated using MicroCal Origin 7.0 using the calculus func-
tion embedded in the software. Integration limits were
chosen to omit the initial 10 min of data to minimize
errors associated with the initiation of the experiment.
The high limit was taken as being the very bottom of the
down-curve of the glucose peak.
Polysome profiling
50 mL of 2 × CBS medium were inoculated with individ-
ual yeast colonies and cultured for up to 72 h in the pres-
ence or absence of 0.5 μg/mL doxycycline at 220 rpm and
30°C. These cultures were used to inoculate fresh 50 mL 2
× CBS medium to a final OD600 of 0.1 and were cultured
as above for 24 h. 50 mL 2 × CBS were inoculated to a final
OD600 of 0.1 from these cultures and grown as stated
above to a final OD600 of 1. Cycloheximide was then
added to the cultures to a final concentration of 10 μg/mL
and incubated for 10 min. Cells were recovered at 5,000 ×
g, 4°C, 5 min, stored on ice and then suspended in 0.4 mL
lysis buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl, 30
mM MgCl2, 200 μg/mL heparin, 50 μg/mL cycloheximide,
1 mM DTT, 1 μl/mL RNase inhibitor and one EDTA-free
protease inhibitor cocktail per 10 mL buffer) prepared in
fresh DEPC-treated water with an equivalent volume of
acid-washed glass beads. The cells were then disrupted in
a Precellys 24 (Bertin Technology, France) at a speed of
6,500 rpm for 10 s. Samples were cooled on ice for 2 min
followed by 2 additional rounds of disruption. The sam-
ples were clarified twice at 5,000 × g, 4°C, 5 min and
10,000 × g, 4°C, 20 min and the supernatant recovered.
The RNA was subsequently quantified at 260 nm on a
Nanodrop (Thermo Fisher Scientific, UK) and 5 – 10
OD600 units loaded on a freshly-prepared 10 mL 10 – 50%
sucrose gradient. Gradients were ultracentrifuged at
37,000 rpm, 4°C in a SW40 Beckman rotor for 2 h 40
Φ = − − − −FCH e ek k t( )1 1 1τPage 12 of 14
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chart recorder (Pharmacia LKB REC 102, GE Healthcare
Life Sciences, UK) by passing the gradient (from the bot-
tom of the tube to the top of the tube) through an Amer-
shamPharmacia UV detector (GE Healthcare Life Sciences,
UK) at a speed of 1.8 mL/min with the simultaneous col-
lection of 0.7 mL fractions. These fractions were stored at
-20°C for later analysis. For EDTA polysome disruption
profiling, yeast cultures were prepared as above and the
cells recovered in the absence of cycloheximide. Cells
were resuspended in 0.4 mL lysis buffer lacking cyclohex-
amide, and disrupted and clarified as above. The RNA was
quantified as previously stated and 10 OD600 units were
mixed with 50 mM EDTA and loaded on top of freshly-
prepared 10 mL 7.5 – 20% sucrose gradients. The gradi-
ents were then ultracentrifuged and processed as
described above.
Analysis of ribosomal RNA
50 mL 2 × CBS medium were inoculated with individual
yeast colonies transformed with the Fps1-HA3 vector and
cultured for up to 48 h in the presence or absence of vari-
ous doxycycline concentrations at 220 rpm and 30°C.
These cultures were used to inoculate fresh 50 mL 2 × CBS
medium containing various doxycycline concentrations
to a final OD600 of 0.1 and were cultured as above to a
final OD600 of 1 – 3. Cells from 0.5 mL culture were col-
lected by centrifugation at 1,000 × g, 4°C for 5 min and
the supernatant discarded. The pellet was then processed
and the RNA collected with an RNeasy Mini Kit (Qiagen)
according to the standard enzymatic lysis protocol for
yeast. The RNA was quantified and samples diluted to 150
ng/μL. The RNA samples were heated to 70°C for 3 min
prior to loading 150 ng samples in triplicate on an Agilent
RNA 6000 Nanochip and running on an Agilent Bioana-
lyzer 2100 according to the manufacturer's instructions.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
NiB and RD were involved in all aspects of the experimen-
tal design, data collection, analysis and interpretation. LG
participated in collecting the bioreactor data. NaB opti-
mized and performed the microcalorimetry experiments.
JW and SB performed the polysome profiling experi-
ments. DP performed the binding assays. MO analyzed
the microcalorimetry data. RB initiated the study, coordi-
nated the data collection, analysis and interpretation, and
drafted the manuscript. All authors contributed to the
final version of the manuscript.
Acknowledgements
We gratefully acknowledge Drs Richard Kemp and Christer Larsson for 
their critical appraisal of our data, and Dr Martin Wilks for advice on the 
presentation of Figure 2. This work was supported by European Commis-
sion contracts LSHG-CT-2004-504601 (E-MeP) and LSHG-CT-2006-
037793 (OptiCryst), and Technology Strategy Board grant TP/7/BIO/6/S/
M0014B to RMB. The BBSRC supports bioreactors and a flow microcalo-
rimeter in the RMB laboratory through an REI award. The work described 
here is the subject of UK patent application number 08132253.2.
References
1. Schlyer S, Horuk R: I want a new drug: G-protein-coupled
receptors in drug development.  Drug Discov Today 2006, 11(11–
12):481-493.
2. Forstner M, Leder L, Mayr LM: Optimization of protein expres-
sion systems for modern drug discovery.  Expert Rev Proteomics
2007, 4(1):67-78.
3. Bonander N, Hedfalk K, Larsson C, Mostad P, Chang C, Gustafsson
L, Bill RM: Design of improved membrane protein production
experiments: Quantitation of the host response.  Protein Sci
2005, 14(7):1729-1740.
4. Andre N, Cherouati N, Prual C, Steffan T, Zeder-Lutz G, Magnin T,
Pattus F, Michel H, Wagner R, Reinhart C: Enhancing functional
production of G protein-coupled receptors in Pichia pastoris
to levels required for structural studies via a single expres-
sion screen.  Protein Sci 2006, 15(5):1115-1126.
5. Islam RS, Tisi D, Levy MS, Lye GJ: Framework for the rapid opti-
mization of soluble protein expression in Escherichia coli
combining microscale experiments and statistical experi-
mental design.  Biotechnol Prog 2007, 23(4):785-793.
6. Martinez Molina D, Wetterholm A, Kohl A, McCarthy AA, Niegowski
D, Ohlson E, Hammarberg T, Eshaghi S, Haeggstrom JZ, Nordlund P:
Structural basis for synthesis of inflammatory mediators by
human leukotriene C4 synthase.  Nature 2007,
448(7153):613-616.
7. Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS, Nord O,
Nygren PA, van Wijk KJ, de Gier JW: Consequences of mem-
brane protein overexpression in Escherichia coli.  Mol Cell Pro-
teomics 2007, 6(9):1527-1550.
8. Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry M,
Hogbom M, van Wijk KJ, Slotboom DJ, Persson JO, et al.: Tuning
Escherichia coli for membrane protein overexpression.  Proc
Natl Acad Sci USA 2008.
9. Bill RM: Yeast – a panacea for the structure-function analysis
of membrane proteins?  Curr Genet 2001, 40(3):157-171.
10. Hedfalk K, Bill RM, Mullins JG, Karlgren S, Filipsson C, Bergstrom J,
Tamas MJ, Rydstrom J, Hohmann S: A regulatory domain in the
C-terminal extension of the yeast glycerol channel Fps1p.  J
Biol Chem 2004, 279(15):14954-14960.
11. Tamas MJ, Karlgren S, Bill RM, Hedfalk K, Allegri L, Ferreira M, Theve-
lein JM, Rydstrom J, Mullins JG, Hohmann S: A short regulatory
domain restricts glycerol transport through yeast Fps1p.  J
Biol Chem 2003, 278(8):6337-6345.
12. Wegierski T, Billy E, Nasr F, Filipowicz W: Bms1p, a G-domain-
containing protein, associates with Rcl1p and is required for
18S rRNA biogenesis in yeast.  RNA 2001, 7(9):1254-1267.
13. Wu PYJ, Ruhlmann C, Winston F, Schultz P: Molecular architec-
ture of the S. cerevisiae SAGA complex.  Mol Cell 2004,
15(2):199-208.
14. Huisinga KL, Pugh BF: A genome-wide housekeeping role for
TFIID and a highly regulated stress-related role for SAGA in
Saccharomyces cerevisiae.  Mol Cell 2004, 13(4):573-585.
15. Kornberg RD: Mediator and the mechanism of transcriptional
activation.  Trends Biochem Sci 2005, 30(5):235-239.
16. Thompson CM, Koleske AJ, Chao DM, Young RA: A Multisubunit
Complex-Associated with the RNA Polymerase-II CTD and
TATA-Binding Protein in Yeast.  Cell 1993, 73(7):1361-1375.
17. Kidane A, Guan Y, Evans P, Kaderbhai M, Kemp R: Comparison of
heat flux in wild-type and genetically-engineered chinese
hamster ovary cells.  J Thermal Anal 1997, 49:771-783.
18. Barford JP: A general model for aerobic yeast growth: Batch
growth.  Biotechnol Bioeng 1990, 35(9):907-920.
19. Mutiu AI, Brandl CJ: RNA isolation from yeast using silica
matrices.  J Biomol Tech 2005, 16(4):316-317.
20. Young BP, Craven RA, Reid PJ, Willer M, Stirling CJ: Sec63p and
Kar2p are required for the translocation of SRP-dependent
precursors into the yeast endoplasmic reticulum in vivo.
EMBO J 2001, 20(1–2):262-271.Page 13 of 14
(page number not for citation purposes)
Microbial Cell Factories 2009, 8:10 http://www.microbialcellfactories.com/content/8/1/10Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
21. Gelperin D, Horton L, Beckman J, Hensold J, Lemmon SK: Bms1p, a
novel GTP-binding protein, and the related Tsr1p are
required for distinct steps of 40S ribosome biogenesis in
yeast.  RNA 2001, 7(9):1268-1283.
22. Karbstein K, Doudna JA: GTP-dependent formation of a ribonu-
cleoprotein subcomplex required for ribosome biogenesis.  J
Mol Biol 2006, 356(2):432-443.
23. Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L,
Montini E, Grompe M, Kozma SC, Thomas G: Proliferation, but
not growth, blocked by conditional deletion of 40S ribos-
omal protein S6.  Science 2000, 288(5473):2045-2047.
24. Hoffmann F, Weber J, Rinas U: Metabolic adaptation of
Escherichia coli during temperature-induced recombinant
protein production: 1. Readjustment of metabolic enzyme
synthesis.  Biotechnol Bioeng 2002, 80(3):313-319.
25. Hoffmann F, Rinas U: On-line estimation of the metabolic bur-
den resulting from the synthesis of plasmid-encoded and
heat-shock proteins by monitoring respiratory energy gen-
eration.  Biotechnol Bioeng 2001, 76(4):333-340.
26. Henricsson C, de Jesus Ferreira MC, Hedfalk K, Elbing K, Larsson C,
Bill RM, Norbeck J, Hohmann S, Gustafsson L: Engineering of a
novel Saccharomyces cerevisiae wine strain with a respiratory
phenotype at high external glucose concentrations.  Appl Envi-
ron Microbiol 2005, 71(10):6185-6192.
27. Gill NK, Appleton M, Lye GJ: Thermal profiling for parallel on-
line monitoring of biomass growth in miniature stirred bio-
reactors.  Biotechnol Lett 2008, 30(9):1571-1575.
28. Rudra D, Warner JR: What better measure than ribosome syn-
thesis?  Genes Dev 2004, 18(20):2431-2436.
29. Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M: Systematic
identification of pathways that couple cell growth and divi-
sion in yeast.  Science 2002, 297(5580):395-400.
30. Smirnova JB, Selley JN, Sanchez-Cabo F, Carroll K, Eddy AA, McCa-
rthy JE, Hubbard SJ, Pavitt GD, Grant CM, Ashe MP: Global gene
expression profiling reveals widespread yet distinctive trans-
lational responses to different eukaryotic translation initia-
tion factor 2B-targeting stress pathways.  Mol Cell Biol 2005,
25(21):9340-9349.
31. Fraser NJ: Expression and functional purification of a glyco-
sylation deficient version of the human adenosine 2a recep-
tor for structural studies.  Protein Expr Purif 2006, 49(1):129-137.
32. Velculescu VE, Zhang L, Zhou W, Vogelstein J, Basrai MA, Bassett DE
Jr, Hieter P, Vogelstein B, Kinzler KW: Characterization of the
yeast transcriptome.  Cell 1997, 88(2):243-251.
33. Poore V, Beezer A: Systematic errors in the measurement of
heat by flow microcalorimetry.  Thermochimica Acta 1983,
63:133-144.Page 14 of 14
(page number not for citation purposes)
